Ensituximab
Appearance
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Chimeric (mouse/human) |
Target | 5AC |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6342H9800N1678O1985S46 |
Molar mass | 142.8 kg/mol g·mol−1 |
(what is this?) (verify) |
Ensituximab is a chimeric monoclonal antibody used in the treatment of cancers.[1]
Ensituximab was developed by Neogenix Oncology, Inc.
References